Clear link between AstraZeneca vaccine and rare blood clots, EMA official

Re:Clear link between AstraZeneca vaccine and rare blood clo... by MrDrDr on Tuesday April 06, 2021 @12:13PM (#26713696)

While this issue is too rare to alter the current vaccine strategy - it does raise an interesting ethical question. What should we do if, for a specific segment of the population, the vaccine poses a greater risk than contracting the virus? Would interesting to try and model this. How would we would/could we chose between the rights of two different population segments?

[ Parent | on HN ]

Re:Clear link between AstraZeneca vaccine and rare blood clo... by linuxftw on Tuesday April 06, 2021 @12:17PM (#26713752)

We should develop a treatment. That's pretty much what we should have been doing all along. If we understand the mechanism of death, we should be able to formulate a protocol to stop/contain that mechanism.

[ Parent | on HN ]

Re:Clear link between AstraZeneca vaccine and rare blood clo... by runeks on Tuesday April 06, 2021 @12:26PM (#26713860)

> How would we would/could we chose between the rights of two different population segments?

What is there to choose between unless we force people to take the vaccine?

[ Parent | on HN ]

Re:Clear link between AstraZeneca vaccine and rare blood clo... by MrDrDr on Tuesday April 06, 2021 @04:21PM (#26716898)

No one can force someone to take a vaccine - but the government can prevent people - or segments of the population - from taking it. By preventing one group taking it, due to health concerns, it may increase the spread of the disease in other more vulnerable groups. Preventing deaths in one group that result in more in another. I guess this is essentially a trolly problem: https://en.wikipedia.org/wiki/Trolley_problem

[ Parent | on HN ]